🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 19 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/10/2011 5,64 5,76 5,46 5,58 -2,11% 5,32% 105.717
24/10/2011 5,40 5,70 5,40 5,70 +5,56% 5,56% 148.233
21/10/2011 5,52 5,58 5,22 5,40 +4,65% 6,52% 144.917
20/10/2011 5,16 5,28 5,10 5,16 +1,18% 3,49% 59.100
19/10/2011 5,28 5,40 5,04 5,10 -4,49% 6,82% 104.683
18/10/2011 5,40 5,40 4,98 5,34 +4,71% 7,78% 152.033
17/10/2011 5,34 5,52 5,04 5,10 -5,56% 8,99% 162.400
14/10/2011 5,28 5,64 4,62 5,40 -14,29% 19,32% 1.244.533
13/10/2011 6,60 6,60 6,12 6,30 -3,67% 7,27% 96.833
12/10/2011 6,60 6,66 6,36 6,54 +3,81% 4,55% 92.683
11/10/2011 6,06 6,30 5,88 6,30 +1,94% 6,93% 105.950
10/10/2011 6,00 6,18 5,64 6,18 +5,10% 9,00% 175.367
07/10/2011 6,24 6,30 5,82 5,88 -5,77% 7,69% 232.467
06/10/2011 6,24 6,30 5,88 6,24 +0,00% 6,73% 180.633
05/10/2011 6,18 6,42 6,00 6,24 +0,00% 6,80% 170.433
04/10/2011 5,76 6,30 5,40 6,24 +6,12% 15,63% 251.150
03/10/2011 6,60 6,66 5,76 5,88 -12,50% 13,64% 244.383
30/09/2011 6,42 6,96 6,42 6,72 +4,67% 8,41% 165.417
29/09/2011 6,48 6,60 6,36 6,42 +1,90% 3,70% 166.250
28/09/2011 6,72 6,84 6,30 6,30 -6,25% 8,04% 218.233
27/09/2011 6,96 6,96 6,54 6,72 -0,88% 6,03% 258.350
26/09/2011 6,96 7,02 6,60 6,78 -0,88% 6,03% 150.350
23/09/2011 6,72 7,02 6,66 6,84 +1,79% 5,36% 115.450
22/09/2011 6,72 6,90 6,60 6,72 -2,61% 4,46% 380.533
21/09/2011 7,20 7,86 6,90 6,90 -4,17% 13,33% 295.533
20/09/2011 7,62 7,86 7,20 7,20 -4,00% 8,66% 209.117
19/09/2011 7,80 7,80 7,38 7,50 -6,72% 5,38% 233.183
16/09/2011 7,50 8,10 7,32 8,04 +8,94% 10,40% 362.500
15/09/2011 7,32 7,44 7,14 7,38 +1,65% 4,10% 127.300
14/09/2011 7,14 7,32 7,02 7,26 +2,54% 4,20% 173.933